HRS-8080

DRUG3 trials

Sponsors

Shandong Suncadia Medicine Co., Ltd., Henan Cancer Hospital

Conditions

Advanced Breast CancerAdvanced Unresectable or Metastatic Breast CancerBreast Cancer

Phase 1

A Clinical Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects

CompletedNCT06619873

Shandong Suncadia Medicine Co., Ltd.Breast Cancer

Start: 2024-10-10End: 2024-11-13Updated: 2026-05-27

A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients

RecruitingNCT06679036

Shandong Suncadia Medicine Co., Ltd.Advanced Unresectable or Metastatic Breast Cancer

Start: 2025-01-21End: 2026-12-31Target: 300Updated: 2026-03-02

Phase 2

SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

Not yet recruitingNCT07125950

Henan Cancer HospitalAdvanced Breast Cancer

Start: 2025-09-30End: 2028-01-31Target: 60Updated: 2025-08-15